Business Segments · Accelerated amortization
Cardiovascular — Accelerated amortization
Medtronic Cardiovascular — Accelerated amortization decreased by 34.8% to $30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 20.5%, from $37.75M to $30M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2025
Last reportedQ3 2026Feb 24, 2026
How to read this metric
An increase signals potential product obsolescence or a strategic decision to phase out certain technologies.
Detailed definition
This represents the non-cash charge taken when the carrying value of an intangible asset in the cardiovascular segment i...
Peer comparison
Comparable to impairment or accelerated amortization charges in the technology-heavy segments of medical device companies.
Metric ID:
mdt_segment_cardiovascular_accelerated_amortizationHistorical Data
7 periods
| Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $37.75M | $37.75M | $37.75M | $37.75M | $45M | $46M | $30M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +19.2% | +2.2% | -34.8% |
| YoY Change | — | — | — | — | +19.2% | +21.9% | -20.5% |
Range$30M – $46M
CAGR-14.2%
Avg YoY Growth+6.8%
Median YoY Growth+19.2%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's cardiovascular — accelerated amortization?
- Medtronic (MDT) reported cardiovascular — accelerated amortization of $30M in Q4 2025.
- How has Medtronic's cardiovascular — accelerated amortization changed year-over-year?
- Medtronic's cardiovascular — accelerated amortization decreased by 20.5% year-over-year, from $37.75M to $30M.
- What does cardiovascular — accelerated amortization mean?
- An extra, non-cash charge for the faster-than-expected decline in value of cardiovascular intangible assets.